GenVivo
Pre-clinicalGenVivo, one of the leading gene therapy companies develops innovative cancer-fighting treatments that significantly improve survival.
Founded
2015
Focus
Drug DeliveryRNA & Gene Therapy
About
GenVivo, one of the leading gene therapy companies develops innovative cancer-fighting treatments that significantly improve survival.
Funding History
2Total raised: $23M
Series A$20MMorningside VenturesAug 15, 2021
Seed$3MUndisclosedNov 15, 2019
Company Info
TypePrivate
Founded2015
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile